- Home
- FOR vs NBTX Comparison
FOR vs NBTX Comparison
Compare FOR & NBTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FOR
- NBTX
- Stock Information
- Founded
- FOR 2005
- NBTX 2003
- Country
- FOR United States
- NBTX France
- Employees
- FOR N/A
- NBTX N/A
- Industry
- FOR Real Estate
- NBTX Biotechnology: Pharmaceutical Preparations
- Sector
- FOR Finance
- NBTX Health Care
- Exchange
- FOR Nasdaq
- NBTX Nasdaq
- Market Cap
- FOR 1.2B
- NBTX 1.3B
- IPO Year
- FOR 2007
- NBTX 2020
- Fundamental
- Price
- FOR $24.54
- NBTX $20.60
- Analyst Decision
- FOR Strong Buy
- NBTX Strong Buy
- Analyst Count
- FOR 4
- NBTX 1
- Target Price
- FOR $31.25
- NBTX $8.00
- AVG Volume (30 Days)
- FOR 128.6K
- NBTX 82.9K
- Earning Date
- FOR 10-28-2025
- NBTX 09-30-2025
- Dividend Yield
- FOR N/A
- NBTX N/A
- EPS Growth
- FOR N/A
- NBTX N/A
- EPS
- FOR 3.29
- NBTX N/A
- Revenue
- FOR $1,662,400,000.00
- NBTX $11,930,711.00
- Revenue This Year
- FOR $1.24
- NBTX N/A
- Revenue Next Year
- FOR $8.97
- NBTX $122.94
- P/E Ratio
- FOR $7.47
- NBTX N/A
- Revenue Growth
- FOR 10.14
- NBTX N/A
- 52 Week Low
- FOR $18.00
- NBTX $2.76
- 52 Week High
- FOR $31.19
- NBTX $30.35
- Technical
- Relative Strength Index (RSI)
- FOR 47.78
- NBTX 51.88
- Support Level
- FOR $22.81
- NBTX $20.32
- Resistance Level
- FOR $25.34
- NBTX $22.25
- Average True Range (ATR)
- FOR 0.79
- NBTX 1.29
- MACD
- FOR -0.07
- NBTX -0.01
- Stochastic Oscillator
- FOR 66.79
- NBTX 49.82
About FOR Forestar Group Inc
Forestar Group Inc is a residential lot development company with operations across the United States. The core business segment for the company is real estate which generates all of it's revenues. The firm fundamentally acquires entitled real estate and develops it into finished residential lots for sale to homebuilders with a strategic focus on asset turns and efficiency. Single-family residential communities account for the majority of their real estate projects. The company utilizes a lower-risk business model mainly by investing in short duration, phased development projects.
About NBTX Nanobiotix S.A.
Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.